Navigation Links
Johnson & Johnson Establishes Susan Lindquist Chair for Women in Science
Date:11/16/2016

NEW BRUNSWICK, N.J., Nov. 16, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the establishment of the Susan Lindquist Chair for Women in Science to honor the life and legacy of Susan L. Lindquist, Ph.D., a globally renowned scientist whose intellectually courageous, boundary defying research significantly advanced science and medicine in the field of protein folding.  Dr. Lindquist, who passed away October 27, left behind a storied career and reputation in biomedical innovation that spanned basic research, entrepreneurship, and mentorship for women in science. The $5 million Chair is endowed in perpetuity at the Whitehead Institute for Biomedical Research and will be awarded to a female scientist to advance biomedical research.

"Sue was a scientific pioneer who changed fundamental understanding of the biology of human health. As part of the Johnson & Johnson Board of Directors, she challenged us to use science and technology in new ways to help improve the health and lives of people all around the world," said Alex Gorsky, Chairman and Chief Executive Officer of Johnson & Johnson. "We are pleased to establish this Chair in Sue's name as a greatly respected and beloved scientist and a passionate advocate for women in science."

An insightful leader with an incomparable perspective on the intersection of academic and commercial medical research, Dr. Lindquist's research changed the scientific community's understanding of protein folding and its role in human health, including diseases such as Parkinson's and Huntington's.  In addition to founding and co-founding multiple biotechnology companies, she served on the Johnson & Johnson Board of Directors since 2004 as Chairman of its Science, Technology & Sustainability Committee and as a member of its Regulatory, Compliance & Government Affairs Committee. When she joined the Whitehead Institute as both a Member and the Institute's Director in 2001, she became the Institute's first female head and one of the first women in the nation to lead a major independent research organization.

David C. Page, M.D., Director of the Whitehead Institute and Professor of Biology at the Massachusetts Institute of Technology (MIT), said, "We are so pleased to partner with Johnson & Johnson to honor Sue's legacy and the impact of women in science. In shaping the focus of this endowed Chair with Sue and Johnson & Johnson, our aim was to ensure the incumbents have great flexibility in how they pursue her legacy of stellar science and courageous leadership."

Dr. Lindquist's personal warmth and generosity were widely admired. As one colleague remembered, "she became one of my dearest mentors—never failing to check in on me, regularly inviting me to lunch to talk about the latest developments in our labs, even thinking to send me a gift to welcome my newborn son. Speaking with Sue always left me with a sense that everything was possible—that one could be a first-class scientist and a first-class human being. The world somehow expanded for all of us because she was in it. Sue made a point of lifting others up and championing younger people—she showed by example that this is how to have maximal impact."

"Sue changed the face of research in so many ways, and she will be deeply missed. We are pleased that her legacy and inspiration continues in her research and in support for other women in science through this new Chair," said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. "She was a phenomenal role model in all ways, to young men and women alike.  She was one of the finest people I have ever had the privilege to know."

Logo - http://photos.prnewswire.com/prnh/20160831/403394LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--johnson-establishes-susan-l-lindquist-chair-for-women-in-science-300364183.html


'/>"/>
SOURCE Johnson & Johnson
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. NantKwest Shareholder (NK) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of NantKwest, Inc.; Encourages Investors to Contact the Firm
2. Novira Therapeutics Announces Acquisition Agreement with Johnson & Johnson
3. OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers
4. enGene announces strategic collaboration with Johnson & Johnson innovation to develop novel gene delivery products for inflammatory bowel disease
5. Neurotech Announces Appointment of Dr. Charles Johnson as Chief Medical Officer
6. Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups
7. Johnson & Johnson Announces Collaboration between Janssen and USAID to Expand Access to Anti-Multidrug-Resistant Tuberculosis (MDR-TB) Compound
8. Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas
9. Conscires presents Certified Scrum Master Training by Lonnie Weaver-Johnson in Raleigh,NC
10. Certified Scrum Product Owner Training by Lonnie Weaver-Johnson in Richmond by Conscires Agile Practices
11. The Holistic Sanctuary Responds to Johnson & Johnson’s Guilty Plea for Selling Risperdal Off-Label
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life ... for the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan ... The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary ...
Breaking Biology Technology:
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
Breaking Biology News(10 mins):